News and Announcements
WYZA Raises $525k in 2017 & Forms Joint Venture
- Published December 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- WYZA Limited has raised $525,000 in the calendar year of 2017.
- WYZA Limited has added a new Company Secretary & CFO, and two non-executive directors.
- WYZA Limited has formed a joint venture with WYZA Money and RFE Group.
Capital Raising to continue in 2018 to support growth.
- This will be achieved through crowdfunding as soon as crowdfunding platform licenses have been issued to Australian platforms. We will grow through the power of THE CROWD.
Additions to staff, Board and Management
- Company Secretary & CFO
Allan Le Gallant, Company Secretary & CFO. Allan has been the Principal of Carlton & Co Accountants for 14 years. Allan qualifications include BComm, MBA, MTax, FCPA, CTA, Chartered Tax Adviser, Tax Institute of Australia, Tax Agent & Public Accountant. - Non-Executive Director
Phillip Bushby is a senior commercial lawyer with over 40 years’ experience. He specialises in international transactions and has extensive expertise in a wide range of commercial activities including Mergers and Acquisitions, Takeovers, Corporate Governance and Government relations. - Non-Executive Director
William Gill has run his own Sydney based corporate advisory business for past 15 years. Prior to that, he had 30 years as an international corporate executive in Europe, USA and Asia. He currently sits on the boards of a number of companies in Singapore and Australia.
New Contracts, MOUs or major clients signed
WYZA MONEY PTY LTD forms a joint venture with WYZA LIMITED and RFE Group.
Full financial services company, offering superannuation, property, retirement planning, life insurance, lending, investment advice, estate planning, wealth accumulation strategies, cash flow optimization and risk management.
About WYZA Limited
Today Australia has over 7.9m people 50+ and this demographic spends $4billion on goods and services each week and holds 40% of Australia’s wealth. WYZA’s growth over the last year has been phenomenal with the WYZA subscriber base increasing over 100% in the last 12 months. Currently on track to have 500,000 on the database by December 2017 with 25 strategic partners.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
